Abacus Global Management, Inc. ( NASDAQ:ABL ) shareholders will doubtless be very grateful to see the share price ...

USC let TCU erase a 10-point fourth quarter Trojans lead to force overtime and failed to tackle during the Horned Frogs' ...

SpaceX mafia startups are raising billions in venture capital, with ex-employees launching companies across aerospace, AI, ...

NovaBridge Also Included in the Highly Regarded Nasdaq Biotech Index, Emphasizing its Position as an Industry Leader Opening ...

In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...

Bitget, the world's largest Universal Exchange (UEX), has released its November 2025 Transparency Report, highlighting sustained growth across derivatives, onchain infrastructure, payments, and ...

The latest accounts for the year up to March 31 show the 2023 turnover of £142,889,169 has fallen to £22,176,487, with an operating profit of just under £67 million falling to less than £1.8million.

Detailed price information for Terns Pharmaceuticals Inc (TERN-Q) from The Globe and Mail including charting and trades.

Detailed price information for Terns Pharmaceuticals Inc (TERN-Q) from The Globe and Mail including charting and trades.

Neuroscience isn't currently one of the top strategic R&D priorities at GSK, but a new alliance with ABL Bio adds to the sense that its focus may be shifting. The UK-headquartered pharma group is ...

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could be ...